Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Pfizer Limited    500680   INE182A01018

PFIZER LIMITED

(500680)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mumbai Stock Exchange
10/23/2020 10/26/2020 10/27/2020 10/28/2020 10/29/2020 Date
5112.85 5188.25 5137.8 5084.55 5031.65 Last
4684 3625 1847 1557 2086 Volume
+1.00% +1.47% -0.97% -1.04% -1.04% Change
Financials
Sales 2021 22 690 M 305 M 305 M
Net income 2021 5 704 M 76,7 M 76,7 M
Net Debt 2021 - - -
P/E ratio 2021 40,4x
Yield 2021 6,43%
Sales 2022 25 328 M 340 M 340 M
Net income 2022 6 128 M 82,4 M 82,4 M
Net Debt 2022 - - -
P/E ratio 2022 37,6x
Yield 2022 0,62%
Capitalization 230 B 3 093 M 3 094 M
Capi. / Sales 2021 10,1x
Capi. / Sales 2022 9,09x
Nbr of Employees 2 489
Free-Float 34,0%
More Financials
Company
Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for Anti-Allergic, Anti-Diabetic, Antihistamine, Anti-Infectives, Cardiovascular, Dermatology, Erectile Dysfunction,... 
Sector
Pharmaceuticals
Calendar
11/17Earnings Release
More about the company
Notations Surperformance© of Pfizer Limited
Trading Rating : Investor Rating :
More Ratings
All news about PFIZER LIMITED
02:36pFauci says first U.S. COVID-19 vaccines could ship late December or early Jan..
RE
11:18aModerna on track to report late-stage COVID-19 vaccine data next month
RE
06:18aANALYSIS : U.S. drugmakers, bracing for price cuts, shift election support towar..
RE
12:56aNext crop of COVID-19 vaccine developers take more traditional route
RE
12:06aBritain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's - T..
RE
10/28REFILE-Japan's Shionogi readies COVID-19 vaccine for December trial- CEO
RE
10/28Senior uk govt sources expect that verdict on whether pfizer backed covid-19 ..
RE
10/28GSK warns COVID-19 will dent full-year earnings
RE
10/28Stock Futures Point to Selloff on Rising Virus Cases
DJ
10/28Stock Futures Point to Selloff on Rising Virus Cases
DJ
10/28Stock Futures Point to Selloff on Rising Virus Cases
DJ
10/28Euro dips on French lockdown fears, U.S. vote drives volatility gauges up
RE
10/27Health Care Shares Fall Amid Earnings Reports -- Health Care Roundup
DJ
10/27Pfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully Enrolled -- 3rd Up..
DJ
10/27EU warns not enough COVID vaccines for all in Europe until 2022
RE
More news
News in other languages on PFIZER LIMITED
10:05aBörse Stuttgart-News: Euwax Trends
09:43aModerna bereitet Start von Corona-Impfstoff vor
09:28aModerna a déjà reçu 1,1 milliard de dollars de dépôts pour son vaccin anti-Co..
10/28US-EXPERTE FAUCI : Vor Januar wird es keinen Corona-Impfstoff geben
10/27Wall Street hésite entre craintes politiques et prouesses technologiques
More news
Analyst Recommendations on PFIZER LIMITED
More recommendations
Chart PFIZER LIMITED
Duration : Period :
Pfizer Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 5 031,65 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Sridhar Subramaniam Managing Director & Executive Director
Rajendra Ambalal Shah Chairman
Deepak Rakheja Director-Global Commercial Operations
Milind Patil Chief Financial Officer & Executive Director
Navin Singhania Director-Business Technology
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER LIMITED19.12%3 135
JOHNSON & JOHNSON-5.15%364 239
ROCHE HOLDING AG-6.18%276 926
PFIZER INC.-9.52%196 991
MERCK & CO., INC.-16.24%192 678
NOVARTIS AG-21.82%179 655